The GSK-3-inhibitor VP2.51 produces antidepressant effects associated with adult hippocampal neurogenesis.

Citation
Pérez-Domper, P., Palomo, V., Gradari, S., Gil, C., de Ceballos, M. L., Martínez, A., & Trejo, J. L. (2017). The GSK-3-inhibitor VP2.51 produces antidepressant effects associated with adult hippocampal neurogenesis. Neuropharmacology, 116, 174–187. https://doi.org/10.1016/j.neuropharm.2016.12.019
DOI:
DOI: 10.1016/j.neuropharm.2016.12.019
Year of publication:
2016
Authors participating in BCBHub:
Ana Martínez